🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In phase Ib, our study is aimed to evaluate the safety and tolerance of SHR...
Status
Recruiting
Location
Fudan Cancer Hospital
Start Date
2025-01-08
Trial ID
NCT06718933
Treatments Being Tested
A randomized, controlled, multicenter clinical study of SHR-A1811 combined ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-30
Trial ID
NCT07355764
Treatments Being Tested
The purpose of this study is to establish a prospective, multi-center platf...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2022-12-30
Trial ID
NCT05594095
This study is a multicentre, open-label, dose-finding/efficacy-expanding ph...
Status
Recruiting
Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Start Date
2025-04-25
Trial ID
NCT06859775
This study is a randomized, open-label, controlled phase II clinical trial....
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-09-30
Trial ID
NCT07776171
The objective is to evaluate the tolerance, safety, pharmacokinetic charact...
Status
Recruiting
Location
Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Start Date
2025-03-18
Trial ID
NCT06840002
This study adopts a randomized, open-label, positive-controlled, multicente...
Status
Not Yet Recruiting
Location
Beijing cancer Hospital
Start Date
2026-07
Trial ID
NCT07676162
This study aimed to evaluate the use of SHR-A1811 in HER2-expression Advanc...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2023-03-31
Trial ID
NCT05769010
Treatments Being Tested
This study is a multi - center, single - arm, open - label, phase Ib/II cli...
Status
Not Yet Recruiting
Location
Tongji Hospital
Start Date
2025-06-01
Trial ID
NCT06990516
Treatments Being Tested
This study aims to evaluate the safety, tolerability, PK and preliminary an...
Status
Unknown
Location
Multiple Locations
Start Date
2023-04
Trial ID
NCT05792410